← Back to catalogue

AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome

FDA UDI

Class I (US FDA UDI)

by LGC Clinical Diagnostics, Inc.

Identity

Trade Name
AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome FDA UDI
Generic Name
SARS-CoV-2 nucleic acid IVD, control FDA UDI
Device Name
AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome (Positive and Negative member-5 X 1.5 ml) FDA UDI
Model / Reference
0505-0159 FDA UDI
Description
AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome (Positive and Negative member-5 X 1.5 ml) FDA UDI

Identifiers

Primary DI / UDI-DI
00816784020987 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
SARS-CoV-2 nucleic acid IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: SARS-CoV-2 nucleic acid IVD, control

AccuPlex SARS-CoV-2 Molecular Controls Kit – Full Genome by LGC Clinical Diagnostics, Inc. — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as SARS-CoV-2 nucleic acid IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5b4a77de-0e1b-496a-b7d7-545d6830b5ae 34 fields · synced Jun 9, 2026